CORDIS
EU research results

CORDIS

English EN

Quick Sepsis Test

Objective

In QUIST, a protein will be validated as a biomarker for early detection and prognosis of sepsis in combination with several other surrogate sepsis biomarkers. Specific objective is:
• To perform a feasibility study in order to gain better insight in the risks and potential hurdles for the validation study in Phase 2 and future exploitation of the project’s results. This study will contain technical, commercial and economical issues.

Expected outcomes:
• A solid businessplan as a result of the feasibility study. This businessplan will contain information that is currently incomplete or lacking about the market (identification of potential customers, competitors, distributors and competing technologies), regulations and industrial partners for the commercial development of a POCT for sepsis. Based on this information, also a strategy will be defined for IP management.
• A research plan for the validation study, addressing technical hurdles defined in the feasibility study.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

ABUNDNZ BV

Address

Brussellaan 7
3446 Al Woerden

Netherlands

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU Contribution

€ 50 000

Project information

Grant agreement ID: 663039

  • Start date

    1 January 2015

  • End date

    30 June 2015

Funded under:

H2020-EU.3.1.3.

  • Overall budget:

    € 71 429

  • EU contribution

    € 50 000

Coordinated by:

ABUNDNZ BV

Netherlands